Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
                
Learn More
Learn More
Roche Diagnostics Cobas™ Liat CT/NG/MG CONTROL Kit
Shop All Roche Diagnostics Products
                    Click to view available options
                
                
                    
                            
                                :
                            
                        
                        
                            
                                CT/NG/MG Control Kit
                            
                        
                    Description
cobas™ liat CT/NG/MG control kit for use with the cobas™ liat CT/NG/MG assay or cobas™ liat CT/NG assay.
 
            Specifications
Specifications
| Certifications/Compliance | CE | 
| Content And Storage | 2°C to 8°C | 
| Concentration | Positive: 3 x 0.3 mL; Negative: 3 x 0.3 mL | 
| Detectable Analytes | Chlamydia trachomatis (CT) nucleic acids, Neisseria gonorrhoeae (NG) nucleic acids | 
| Format | 3 sets of positive and negative controls per kit | 
| For Use With (Equipment) | cobas™ liat analyzer CT/NG and CT/NG/MG assay kits | 
| Sample Type | Urine, Swab | 
| Type | IVD Control | 
| Includes | 3 sets of positive and negative controls per kit | 
| Intended Use | Control tests to be used for the cobas™ liat CT/NG and CT/NG/MG assays. The cobas™ liat CT/NG/MG test is an automated, qualitative in vitro nucleic acid diagnostic using real-time PCR for the detection of CT, NG, and MG in male urine and vaginal swabs. The cobas™ liat CT/NG test is an automated, qualitative in vitro nucleic acid diagnostic using real-time PCR for the detection of CT and NG in male urine and vaginal swabs. | 
| Show More | 
                    Product Content Correction
                
                Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
			
            Spot an opportunity for improvement?Share a Content Correction
            